Occurrence and clinical management of moderate-to-severe adverse events during drug-resistant tuberculosis treatment: a retrospective cohort study
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacy,Health Policy
Link
http://link.springer.com/content/pdf/10.1186/2052-3211-7-14.pdf
Reference16 articles.
1. Ministry of Health and Social Services (MoHSS): National Tuberculosis and Leprosy Programme 2011–2012 Annual Report. 2012, Windhoek: MoHSS
2. Marks DJB, Dheda K, Dawson R, Ainslie G, Miller RF: Adverse events to antituberculosis therapy: influence of HIV and antiretroviral drugs. Int J STD AIDS. 2009, 20 (5): 339-345.
3. Venkatesh KK, Swaminathan S, Andrews JR, Mayer KH: Tuberculosis and HIV co-infection: screening and treatment strategies. Drugs. 2011, 71 (9): 1133-1152.
4. Schaberg T, Rebhan K, Lode H: Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis. Eur Respir J. 1996, 9 (10): 2026-2030.
5. Chung-Delgado K, Revilla-Montag A, Guillen-Bravo S, Velez-Segovia E, Soria-Montoya A, Nuñez-Garbin A, Silva-Caso W, Bernabe-Ortiz A: Factors associated with anti-tuberculosis medication adverse effects: a case–control study in Lima, Peru. PLoS One. 2011, 6 (11): e27610.
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Variation of adverse drug events in different settings in Africa: a systematic review;European Journal of Medical Research;2024-06-16
2. Frequency, management and impact of adverse events on treatment outcomes in patients with multidrug resistant tuberculosis in Balochistan, Pakistan;Journal of Pharmaceutical Policy and Practice;2024-04-02
3. Comparative effectiveness of individualized longer and standardized shorter regimens in the treatment of multidrug resistant tuberculosis in a high burden country;Frontiers in Pharmacology;2022-09-06
4. Assessment of Adverse Drug Events, Their Risk Factors, and Management Among Patients Treated for Multidrug-Resistant TB: A Prospective Cohort Study From Pakistan;Frontiers in Pharmacology;2022-05-17
5. Relationship of Hearing Impairment in Patients with Lamivudine Therapy: A Systematic Review and Meta-analysis;JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3